AI imaging to measure gut lining damage in IBD
Part of Digestive system clinical trials.
This pilot study uses a special AI-powered camera and a safe fluorescent dye during your scheduled colonoscopy to map how much fluid leaks through your gut lining. The goal is to better understand gut barrier damage in inflammatory bowel disease and help doctors assess disease severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have ulcerative colitis or Crohn's disease affecting the colon, or you are a healthy control person getting a screening colonoscopy
- You are already scheduled for a colonoscopy for medical reasons
- You are not allergic to fluorescein (a yellow-orange dye used in eye exams)
- You are not pregnant, breastfeeding, or taking NSAIDs or antibiotics right now
- You can handle the bowel prep and tolerate the full colonoscopy procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to combine CT/MR scans and colonoscopy images to better diagnose and predict outcomes for people with inflammatory bowel disease, intestinal tuberculosis, or Behçet's disease. It aims to see if AI can help doctors make more accurate decisions.
This study uses a special AI system that analyzes images from a colonoscopy to help doctors better understand how active your ulcerative colitis is and predict how it might progress. If you are scheduled for a routine colonoscopy, this AI tool may help your doctor make more precise treatment decisions.
This trial uses AI to improve MRI scans for detecting intestinal fibrosis (scarring) in people with Crohn's disease who are scheduled for surgery. It aims to help doctors better identify and treat scarring.
This study tests whether an artificial intelligence (AI) system can help doctors find signs of Crohn's disease better than standard reading of capsule endoscopy images. It is for people who have symptoms that might be Crohn's but whose colonoscopy didn't clearly show the problem.
This study tests whether artificial intelligence can help doctors see colorectal lesions more clearly using special advanced imaging. If you have a colorectal lesion, this trial may help improve diagnosis.
This trial uses artificial intelligence during colonoscopy to predict if Crohn's disease will come back after surgery. It aims to improve early detection and guide treatment decisions.
Hear when a new Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.